| Product NDC: | 59746-002 |
| Proprietary Name: | Methylprednisolone |
| Non Proprietary Name: | Methylprednisolone |
| Active Ingredient(s): | 8 mg/1 & nbsp; Methylprednisolone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59746-002 |
| Labeler Name: | JUBILANT CADISTA PHARMACEUTICALS, INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040189 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19971031 |
| Package NDC: | 59746-002-06 |
| Package Description: | 100 TABLET in 1 BOTTLE (59746-002-06) |
| NDC Code | 59746-002-06 |
| Proprietary Name | Methylprednisolone |
| Package Description | 100 TABLET in 1 BOTTLE (59746-002-06) |
| Product NDC | 59746-002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methylprednisolone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19971031 |
| Marketing Category Name | ANDA |
| Labeler Name | JUBILANT CADISTA PHARMACEUTICALS, INC. |
| Substance Name | METHYLPREDNISOLONE |
| Strength Number | 8 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |